89 related articles for article (PubMed ID: 164475)
61. Bromodeoxyuridine (BUdR) treatment of melanoma cells decreases cellular proteolytic activity.
Evans I; Bosmann HB
Exp Cell Res; 1977 Aug; 108(1):151-5. PubMed ID: 19270
[No Abstract] [Full Text] [Related]
62. Chromosome banding by in vitro exposure to dA-dT probes and BUdR. Relationships between DNA base clusters, replication pattern, and banding.
Rønne M; Thust R
Hereditas; 1983; 99(2):245-50. PubMed ID: 6668210
[No Abstract] [Full Text] [Related]
63. Is bromodeoxyuridine resistance a consequence of cytokinin habituation in Nicotiana tabacum?
Kandra G; Maliga P
Planta; 1977 Jan; 133(2):131-3. PubMed ID: 24425215
[TBL] [Abstract][Full Text] [Related]
64. Incorporation of 5-bromodeoxyuridine into DNA in newborn rat tissues.
Margison GP; Likhachev AJ; Tomatis L
Chem Biol Interact; 1980 Jun; 30(3):297-303. PubMed ID: 7379209
[TBL] [Abstract][Full Text] [Related]
65. Serum requirement and density dependent inhibition of human malignant glioma cells in culture.
Lindgren A; Westermark B
Exp Cell Res; 1977 Feb; 104(2):293-9. PubMed ID: 837979
[No Abstract] [Full Text] [Related]
66. Induction of lupus inclusions by BUdR is mediated by a human lymphoid cell factor.
Rich SA
Arthritis Rheum; 1981 Nov; 24(11):1444-7. PubMed ID: 6274360
[No Abstract] [Full Text] [Related]
67. Variability of cell cycle times measured in vivo in embryonic chick retina by continuous labelling with BUdR.
Morris VB; Cowan R; Culpin D
Nature; 1979 Jul; 280(5717):68-71. PubMed ID: 15305582
[No Abstract] [Full Text] [Related]
68. [Action of deoxyuridine on the inhibition of the rhizogenesis and the hypocotyl growth observed in the presence of 5-bromodeoxyuridine in the cuttings of etiolated tomato seedlings].
Gullot A
Planta; 1971 Jun; 102(2):127-33. PubMed ID: 24482130
[TBL] [Abstract][Full Text] [Related]
69. 5-Bromodeoxyuridine: A specific inhibitor of cytokinin-habituation in tobacco cell culture.
Meins F
Planta; 1976 Jan; 129(3):239-44. PubMed ID: 24430963
[TBL] [Abstract][Full Text] [Related]
70. Studies on Synergism in Combinations of Anti-Tumour Agents in Chick Embryos.
Diwan BA; Batra BK
Wilhelm Roux Arch Entwickl Mech Org; 1971 Dec; 167(4):353-359. PubMed ID: 28304560
[TBL] [Abstract][Full Text] [Related]
71. A cautionary note on the use of BUdR when determining micronucleus frequencies.
Boyes BG; Koval JJ
Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Mar; 47(3):341-2. PubMed ID: 3872285
[No Abstract] [Full Text] [Related]
72. Studies on the enhanced interaction of halodeoxyuridine-substituted DNAs with H1 histones and other polypeptides.
Fasy TM; Cullen BR; Luk D; Bick MD
J Biol Chem; 1980 Feb; 255(4):1380-7. PubMed ID: 7354034
[No Abstract] [Full Text] [Related]
73. STUDIES ON ANTIBODY PRODUCTION : VII. THE EFFECT OF 5-BROMODEOXYURIDINE ON THE IN VITRO ANAMNESTIC ANTIBODY RESPONSE.
O'Brien TF; Coons AH
J Exp Med; 1963 Jun; 117(6):1063-74. PubMed ID: 19867230
[TBL] [Abstract][Full Text] [Related]
74. Effect of 5-bromodeoxyuridine on heterogeneous nuclear RNA in rat hepatoma cells.
Weber HW; Stellwagen RH
Nucleic Acids Res; 1979 Apr; 6(4):1731-46. PubMed ID: 36602
[TBL] [Abstract][Full Text] [Related]
75. Requirement of bromodeoxyuridine for the maintenance of "transformed" characteristics in bromodeoxyuridine dependent cells.
Horn D; Davidson RL
J Cell Physiol; 1975 Apr; 85(2 Pt 1):251-60. PubMed ID: 164475
[TBL] [Abstract][Full Text] [Related]
76. Dissociation of plasminogen activator from the transformed phenotype in a 5-bromodeoxyuridine dependent mutant of Syrian hamster melanoma cells.
Rosenthal SL; Zucker D; Davidson RL
J Cell Physiol; 1978 Jun; 95(3):275-85. PubMed ID: 649664
[TBL] [Abstract][Full Text] [Related]
77. Bromodeoxyuridine-induced reversion of transformed characteristics in BHK21 cells: changes at the plasma membrane level.
Lage-Davila A; Krust B; Hofmann-Clerc F; Torpier G; Montagnier L
J Cell Physiol; 1979 Jul; 100(1):95-107. PubMed ID: 468922
[TBL] [Abstract][Full Text] [Related]
78. Reversible "transformation" of bromodeoxyuridine-dependent cells by bromodeoxyuridine.
Davidson RL; Horn D
Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3338-42. PubMed ID: 4530304
[TBL] [Abstract][Full Text] [Related]
79. The dissociation of the surface architecture described by enhanced lectin agglutinability and the transformed phenotype expressed as anchorage independence.
Noonan KD; Bouck N; di Mayorica G
J Cell Physiol; 1977 May; 91(2):201-7. PubMed ID: 193864
[TBL] [Abstract][Full Text] [Related]
80. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
Nagashima T; Hoshino T
No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
